Literature DB >> 21967816

Insulin resistance and metabolic hepatocarcinogenesis with parent-of-origin effects in A×B mice.

Ian N Hines1, Hadley J Hartwell, Yan Feng, Elizabeth J Theve, Gregory A Hall, Sara Hashway, Jessica Connolly, Michelle Fecteau, James G Fox, Arlin B Rogers.   

Abstract

Insulin resistance is a defining feature of metabolic syndrome and type 2 diabetes mellitus but also may occur independently of these conditions. Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of these disorders, increases the risk of hepatocellular carcinoma (HCC). However, mechanisms linking hyperinsulinemia to NAFLD and HCC require clarification. We describe a novel model of primary insulin resistance and HCC with strong parent-of-origin effects. Male AB6F1 (A/JCr dam × C57BL/6 sire) but not B6AF1 (B6 dam × A/J sire) mice developed spontaneous insulin resistance, NAFLD, and HCC without obesity or diabetes. A survey of mitochondrial, imprinted, and sex-linked traits revealed modest associations with X-linked genes. However, a diet-induced obesity study, including B6.A chromosome substitution-strain (consomic) mice, showed no segregation by sex chromosome. Thus, parent-of-origin effects were specified within the autosomal genome. Next, we interrogated mechanisms of insulin-associated hepatocarcinogenesis. Steatotic hepatocytes exhibited adipogenic transition characterized by vacuolar metaplasia and up-regulation of vimentin, adipsin, fatty acid translocase (CD36), peroxisome proliferator-activated receptor-γ, and related products. This profile was largely recapitulated in insulin-supplemented primary mouse hepatocyte cultures. Importantly, pyruvate kinase M2, a fetal anabolic enzyme implicated in the Warburg effect, was activated by insulin in vivo and in vitro. Thus, our study reveals parent-of-origin effects in heritable insulin resistance, implicating adipogenic transition with acquired anabolic metabolism in the progression from NAFLD to HCC.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21967816      PMCID: PMC3260805          DOI: 10.1016/j.ajpath.2011.08.014

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

Review 1.  Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms.

Authors:  Olga Giouleme; Michael D Diamantidis; Marios G Katsaros
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

2.  Gene expression profile of long-lived Ames dwarf mice and Little mice.

Authors:  Daniel Amador-Noguez; Kazuo Yagi; Susan Venable; Gretchen Darlington
Journal:  Aging Cell       Date:  2004-12       Impact factor: 9.304

3.  Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease.

Authors:  Kausik Das; Kshaunish Das; Partha S Mukherjee; Alip Ghosh; Sumantra Ghosh; Asit R Mridha; Tapan Dhibar; Bhaskar Bhattacharya; Dilip Bhattacharya; Byomkesh Manna; Gopal K Dhali; Amal Santra; Abhijit Chowdhury
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

4.  Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation.

Authors:  Tsung-Ming Chen; Chun-Che Lin; Pi-Teh Huang; Chen-Fan Wen
Journal:  J Gastroenterol Hepatol       Date:  2011-05       Impact factor: 4.029

5.  Evidence for an alternative glycolytic pathway in rapidly proliferating cells.

Authors:  Matthew G Vander Heiden; Jason W Locasale; Kenneth D Swanson; Hadar Sharfi; Greg J Heffron; Daniel Amador-Noguez; Heather R Christofk; Gerhard Wagner; Joshua D Rabinowitz; John M Asara; Lewis C Cantley
Journal:  Science       Date:  2010-09-17       Impact factor: 47.728

6.  Identification of individuals with insulin resistance using routine clinical measurements.

Authors:  Steven E Stern; Ken Williams; Eleuterio Ferrannini; Ralph A DeFronzo; Clifton Bogardus; Michael P Stern
Journal:  Diabetes       Date:  2005-02       Impact factor: 9.461

7.  Obesity and non-insulin-dependent diabetes mellitus in Swiss-Webster mice associated with late-onset hepatocellular carcinoma.

Authors:  Laura B Lemke; Arlin B Rogers; Prashant R Nambiar; James G Fox
Journal:  J Endocrinol       Date:  2008-07-30       Impact factor: 4.286

8.  Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.

Authors:  J G Fox; F E Dewhirst; J G Tully; B J Paster; L Yan; N S Taylor; M J Collins; P L Gorelick; J M Ward
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

9.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.

Authors:  Heather R Christofk; Matthew G Vander Heiden; Marian H Harris; Arvind Ramanathan; Robert E Gerszten; Ru Wei; Mark D Fleming; Stuart L Schreiber; Lewis C Cantley
Journal:  Nature       Date:  2008-03-13       Impact factor: 49.962

10.  Genetic factors for resistance to diet-induced obesity and associated metabolic traits on mouse chromosome 17.

Authors:  Carrie A Millward; Lindsay C Burrage; Haifeng Shao; David S Sinasac; Jean H Kawasoe; Annie E Hill-Baskin; Sheila R Ernest; Aga Gornicka; Chang-Wen Hsieh; Sorana Pisano; Joseph H Nadeau; Colleen M Croniger
Journal:  Mamm Genome       Date:  2009-01-10       Impact factor: 2.957

View more
  13 in total

1.  Canonical variate regression.

Authors:  Chongliang Luo; Jin Liu; Dipak K Dey; Kun Chen
Journal:  Biostatistics       Date:  2016-02-09       Impact factor: 5.899

2.  Stress of Strains: Inbred Mice in Liver Research.

Authors:  Arlin B Rogers
Journal:  Gene Expr       Date:  2018-08-09

3.  Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice.

Authors:  Hadley J Hartwell; Keiko Y Petrosky; James G Fox; Nelson D Horseman; Arlin B Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

4.  Low adipocyte hepatocellular carcinoma is associated with aggressive cancer biology and with worse survival.

Authors:  Swagoto Mukhopadhyay; Yoshihisa Tokumaru; Masanori Oshi; Itaru Endo; Kazuhiro Yoshida; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

5.  Genetic control of obesity, glucose homeostasis, dyslipidemia and fatty liver in a mouse model of diet-induced metabolic syndrome.

Authors:  D S Sinasac; J D Riordan; S H Spiezio; B S Yandell; C M Croniger; J H Nadeau
Journal:  Int J Obes (Lond)       Date:  2015-09-18       Impact factor: 5.095

Review 6.  The metabolomic window into hepatobiliary disease.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  J Hepatol       Date:  2013-05-25       Impact factor: 25.083

Review 7.  Chromosome substitution strains: gene discovery, functional analysis, and systems studies.

Authors:  Joseph H Nadeau; Jiri Forejt; Toyoyuki Takada; Toshihiko Shiroishi
Journal:  Mamm Genome       Date:  2012-09-08       Impact factor: 2.957

8.  Identification of eQTLs for hepatic Xbp1s and Socs3 gene expression in mice fed a high-fat, high-caloric diet.

Authors:  Sarina Pasricha; Jane Kenney-Hunt; Kristy Anderson; Nadereh Jafari; Rabea A Hall; Frank Lammert; James Cheverud; Richard M Green
Journal:  G3 (Bethesda)       Date:  2015-01-23       Impact factor: 3.154

Review 9.  Obesity and cancer progression: is there a role of fatty acid metabolism?

Authors:  Seher Balaban; Lisa S Lee; Mark Schreuder; Andrew J Hoy
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

10.  Sex-Specific Parental Effects on Offspring Lipid Levels.

Authors:  Irene M Predazzi; Rafal S Sobota; Serena Sanna; William S Bush; Jacquelaine Bartlett; Jessica S Lilley; MacRae F Linton; David Schlessinger; Francesco Cucca; Sergio Fazio; Scott M Williams
Journal:  J Am Heart Assoc       Date:  2015-06-30       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.